Recent news and posts
Two mini-HTAs regarding brachytherapy for esophageal cancer and targeted gene deep-sequencing panels were initiated by Oslo University Hospital in May of 2018
Norway established in 2013 a framework for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. This framework is called the “New Method”.
In this framework, all innovations should undergo HTA before being funded. If the method concerns only one or two hospitals, assessment shall be initiated by clinicians and ran at the hospital level. The final report is disseminated via a mini-HTA database. If the method is of national concern, it undergoes Single Technology Appraisal at national level followed by the funding decision by the group of payers (Decision Forum, Beslutningsforum).
In May of 2018, two mini-method assessments were initiated by Oslo University Hospital:
- Brachytherapy for esophageal cancer
- Targeted gene deep-sequencing panels
All finalized mini-method assessments will be published in the National Database for Mini-Method Assessments.
See the full details in Norwegian here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.